Vincent speaks with members of Prometheus, a team of academic and industrial scientists assembled to develop antibody-based therapeutics against infections caused by tick-borne Crimean-Congo hemorrhagic fever virus and rodent-borne hantaviruses, for which no approved vaccines or specific drugs are available.
Kartik Chandran, Zachary Bornholdt, Steven Bradfute, John Dye, Matthias Forsell, Jason McLellan, Laura Walker, and Cecelia Vial.
Links for This Episode
- NIH U19 grant mechanism.
- $22 million Prometheus grant.
- Timestamps by Jolene. Thanks!
Send your virology questions and comments to email@example.com
Subscribe (free): iTunes, Google Podcasts, RSS, email.
Become a patron of TWiV!
Intro music is by Ronald Jenkees.